Summary : The U.S. Food and Drug Administration issued a Complete Response Letter (CRL) to Gilead Sciences rejecting its New Drug Application…
ChemRobotics Pvt. Ltd. © 2023, All Rights Reserved.
Designed and Developed by Ample eBusiness
Tag:
Reverse
-
-
GileadGlobal MarketPatentsRegulatory
Gilead’s Strong Financials Marred by $1.25B ViiV Patent Settlement
by adminby adminSummary : This week, Gilead Sciences took a $1.25 billion hit after reaching a settlement with ViiV Healthcare on a patent dispute…
-
Active Pharmaceutical Ingredients (API)BictegravirEmtricitabineTenofovir Alafenamide
USFDA Approves Expanded Indication of Gilead’s Biktarvy for Treatment of HIV-1 in Pediatric Populations
by adminby adminKeypoints FDA Approves Low-Dose Tablet for HIV Treatment in Virologically Suppressed Children Weighing at Least 14 kg. Biktarvy Provides an Effective Treatment…
-
Active Pharmaceutical Ingredients (API)Chugai Pharmaceuticals and Oncolys BioPhamaCompaniesTelomelysin
Oncolys BioPharma and Chugai Pharmaceuticals agree to Terminate Exclusive License Agreement on Oncolytic Viral Immunotherapy, OBP-301(Telomelysin)
by adminby adminKeypoints: Chugai, Oncolys BioPharma agree to terminate exclusive license agreement on oncolytic viral immunotherapy, OBP-301 The effective date of the termination will…